Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,971.22
(
0.37%
)
News Focus
News Focus

Replies to post #224133 on Biotech Values

Replies to #224133 on Biotech Values
icon url

DewDiligence

03/18/19 11:33 AM

#224136 RE: James salmon #224133

Yes, timing matters a lot. However, I'm not sure FDA concurrence with ADXS' proposed AIM2CERV design change will be a market-moving event. Ditto for lifting of the partial clinical hold on AIM2CERV.